Viewing Study NCT00445172



Ignite Creation Date: 2024-05-05 @ 5:23 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00445172
Status: COMPLETED
Last Update Posted: 2023-06-18
First Post: 2007-03-06

Brief Title: A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis ALS
Sponsor: Eisai Co Ltd
Organization: Eisai Inc

Study Overview

Official Title: A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis ALS
Status: COMPLETED
Status Verified Date: 2017-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to investigate the safety and efficacy of long-term E0302 administration in patients with Amyotrophic Lateral Sclerosis ALS
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None